SCHEMBL24315877

SCHEMBL24315877

CC(C)c1ccc(N(C)C)[nH]c1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 2/20 0.35
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
CHEK1 O14757 1/20 0.33
AURKA O14965 1/20 0.33
MAP4K4 O95819 1/20 0.33
ABL1 P00519 1/20 0.33
CSF1R P07333 1/20 0.33
RET P07949 1/20 0.33
MET P08581 1/20 0.33
FGFR1 P11362 1/20 0.33
PDGFRA P16234 1/20 0.33
FLT1 P17948 1/20 0.33
LTK P29376 1/20 0.33
GRK5 P34947 1/20 0.33
CSNK1A1 P48729 1/20 0.33
CDK8 P49336 1/20 0.33
CLK2 P49760 1/20 0.33
CDK7 P50613 1/20 0.33
CDK9 P50750 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20204612 0.75 CA1 (0.38) DAOHPGDCHEK1AURKAMAP4K4
SCHEMBL14793837 0.72 HMBS (0.43) DAOCHEK1AURKAMAP4K4ABL1
SCHEMBL12180269 0.72 DAO (0.39) DAOALDH1A1HPGDCHEK1AURKA
SCHEMBL26620926 0.72 DAO (0.39) DAOALDH1A1HPGDKDM4E
SCHEMBL19372888 0.71 CHEK1 (0.39) DAOALDH1A1CHEK1AURKAMAP4K4
SCHEMBL24315871 0.71 EIF4A3 (0.37) DAOCHEK1AURKAMAP4K4ABL1
SCHEMBL4265547 0.69 ALDH1A1 (0.39) DAOALDH1A1
SCHEMBL24315863 0.68 HCAR2 (0.34) DAOCHEK1AURKAMAP4K4ABL1
SCHEMBL24315859 0.68 CHEK1 (0.33) DAOALDH1A1CHEK1AURKAMAP4K4
SCHEMBL22185346 0.68 PARP1 (0.41) DAOCHEK1AURKAMAP4K4ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081925-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed
US-9585884-B2 Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 AUSPEX PHARMACEUTICALS, INC. (US) 2017-03-07 US disclosed